[1] LI G X, YILMAZ M, KOJICIC M, et al. Outcome of critically ill patients with influenza virus infection[J]. J Clin Virol, 2009, 46(3): 275-278. DOI: 10.1016/j.jcv.2009.07.015. [2] 龚慧,申鑫,严涵,等. 2006—2019年中国季节性流感疾病负担估计[J].中华医学杂志, 2021, 101(8): 560-567. DOI: 10.3760/cma.j.cn112137-20201210-03323. [3] 中华人民共和国国家卫生健康委员会.流行性感冒诊疗方案(2020年版)[J].全科医学临床与教育, 2020, 18(12): 1059-1063. DOI: 10.13558/j.cnki.issn1672-3686.2020.012.002. [4] 张代涛,刘重程,赵小娟,等.北京市2018—2019流行季流感的发病率和住院率研究[J].国际病毒学杂志, 2020, 27(1): 23-26. DOI: 10.3760/cma.j.issn.1673-4092.2020.01.006. [5] TAVARES L P, TEIXEIRA M M, GARCIA C C. The inflammatory response triggered by Influenza virus: a two edged sword[J]. Inflamm Res, 2017, 66(4): 283-302. DOI: 10.1007/s00011-016-0996-0. [6] CHEN C, SUN W, CHEN J, et al. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: a retrospective small-scale study[J]. Exp Ther Med, 2017, 13(4): 1490-1494. DOI: 10.3892/etm.2017.4144. [7] 耿陶然,韩扬,邱志峰,等.重症流行性感冒患者T淋巴细胞与预后研究[J]. 中华内科杂志, 2020, 59(3): 200-206. DOI: 10.3760/cma.j.issn.0578-1426.2020.03.006. [8] 陈凤欣,赵银连,李蕴铷,等.甲型H1N1流感患者的免疫学特征分析[J].中国全科医学, 2010, 13(19): 2118-2119. DOI: 10.3969/j.issn.1007-9572.2010.19.021. [9] ROBERTS N J Jr. Diverse and unexpected roles of human monocytes/macrophages in the immune response to influenza virus[J]. Viruses, 2020, 12(4): 379. DOI: 10.3390/v12040379. [10] YANG K, ZHANG N, GAO C C, et al. Risk factors for hospital-acquired influenza A and patient characteristics: a matched case-control study[J]. BMC Infect Dis, 2020, 20(1): 863. DOI: 10.1186/s12879-020-05580-9. [11] 吉茂礼,程涛.甲型H1N1流感病毒RNA定量分析在轻型与肺炎患者中的应用[J].陕西医学杂志, 2018, 47(11): 1503-1506. DOI: 10.3969/j.issn.1000-7377.2018.11.041. [12] 钱永兵,谢晖,田锐,等.早期免疫功能麻痹在重症甲型H1N1流感中的临床意义[J].中华危重病急救医学, 2017, 29(7): 581-585. DOI: 10.3760/cma.j.issn.2095-4352.2017.07.002. [13] 张玮宸,裴玉芳.流感患者外周血C反应蛋白、淋巴细胞与肺炎严重度指数的相关性分析[J].武警医学, 2020, 31(6): 486-489. DOI: 10.14010/j.cnki.wjyx.2020.06.008. [14] 李靖,屠蒙,徐喆选,等.T淋巴细胞亚群对重症甲型流感患者预后的评估价值[J].医学研究生学报, 2019, 32(11): 1174-1178. DOI: 10.16571/j.cnki.1008-8199.2019.11.011. [15] 杨丰赫,叶菁菁,郑铭.程序性细胞死亡分子5(PDCD5)研究进展[J].生理科学进展, 2021, 52(1): 1-6. [16] ZHUGE C J, SUN X J, CHEN Y Y, et al. PDCD5 functions as a regulator of p53 dynamics in the DNA damage response[J]. J Theor Biol, 2016, 388: 1-10. DOI: 10.1016/j.jtbi.2015.09.025. [17] LI P H, FEI H X, WANG L H, et al. PDCD5 regulates cell proliferation, cell cycle progression and apoptosis[J]. Oncol Lett, 2018, 15(1): 1177-1183. DOI: 10.3892/ol.2017.7401. [18] 李明,苏维,马士恒,等.甲型H1N1型流感患者外周血程序化细胞死亡分子5表达水平及其与疾病严重程度的相关性[J].医学研究生学报, 2018, 31(6): 636-640. DOI: 10.16571/j.cnki.1008-8199.2018.06.015. |